Bayer Healthcare issues important Trasylol safety info

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1091, 2006-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bayer issues new Trasylol safety info in Canada

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Support for safety of Aleve leaves Bayer pleased

Reactions Weekly, Vol. 1, Iss. 1041, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Bayer HealthCare Pharmaceuticals will award $US2.75 million in funding through the Bayer Hemophilia Awards Program (BHAP)

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 504, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

New Avastin safety info issued in Canada

Reactions Weekly, Vol. 1, Iss. 1157, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Labelling for Ketek updated in Canada with new safety info

Reactions Weekly, Vol. 1, Iss. 1122, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite